Results 21 to 30 of about 100,759 (296)

Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)

open access: yesMethodsX, 2021
The blood-brain barrier (BBB) is the major obstacle for brain drug delivery and limits the treatment options for central nervous system diseases. To circumvent the BBB, we introduce focused ultrasound-mediated intranasal brain drug delivery (FUSIN ...
Dezhuang Ye, Hong Chen
doaj   +1 more source

Nasal Drug Delivery Systems: An Overview [PDF]

open access: yes, 2015
Since ancient times, drugs have been administered via the nasal route for therapeutic and recreational purposes. The interest in, and importance, of the systemic effects of drugs administered through the nasal route, have expanded over recent decades ...
Conway, Barbara R.   +3 more
core   +1 more source

Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment

open access: yesPharmaceutics, 2020
Direct nose-to-brain delivery has been raised as a non-invasive powerful strategy to deliver drugs to the brain bypassing the blood-brain barrier (BBB). This study aimed at preparing and characterizing an innovative composite formulation, associating the
Thomas Adnet   +10 more
doaj   +1 more source

A selective role for neuronal activity regulated pentraxin in the processing of sensory-specific incentive value [PDF]

open access: yes, 2007
Neuronal activity regulated pentraxin (Narp) is a secreted neuronal product which clusters AMPA receptors and regulates excitatory synaptogenesis. Although Narp is selectively enriched in brain, its role in behavior is not known.
Baraban, Jay M   +6 more
core   +1 more source

Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles [PDF]

open access: yesAAPS PharmSciTech, 2015
The objective of the present investigation was to optimize diazepam (Dzp)-loaded poly(lactic-co-glycolic acid) nanoparticles (NP) to achieve delivery in the brain through intranasal administration. Dzp nanoparticles (DNP) were formulated by nanoprecipitation and optimized using Box-Behnken design. The influence of various independent process variables (
Deepak, Sharma   +6 more
openaire   +2 more sources

Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? [PDF]

open access: yes, 2018
Although several viruses can easily infect the central nervous system (CNS), antiviral drugs often show dramatic difficulties in penetrating the brain from the bloodstream since they are substrates of active efflux transporters (AETs). These transporters,
Dalpiaz, Alessandro, Pavan, Barbara
core   +2 more sources

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

open access: yesPharmaceutics, 2022
Neurological diseases continue to increase in prevalence worldwide. Combined with the lack of modifiable risk factors or strongly efficacious therapies, these disorders pose a significant and growing burden on healthcare systems and societies.
Tyler P. Crowe, Walter H. Hsu
doaj   +1 more source

Selective disruption of stimulus-reward learning in glutamate receptor gria 1 knockout mice. [PDF]

open access: yes, 2003
Glutamatergic neurotransmission via AMPA receptors has been an important focus of studies investigating neuronal plasticity. AMPA receptor glutamate receptor 1 (GluR1) subunits play a critical role in long-term potentiation (LTP).
Mead, Andy N, Stephens, David N
core   +2 more sources

Nose-to-brain delivery of tacrine

open access: yesJournal of Pharmacy and Pharmacology, 2007
Abstract In the treatment of Alzheimer's disease tacrine, a cholinesterase inhibitor, is not the drug of choice due to its low oral bioavailability, extensive hepatic first-pass effect, rapid clearance from the systemic circulation, pronounced hepatotoxicity, and the availability of drugs better than tacrine in the same pharmacological ...
Viral V, Jogani   +4 more
openaire   +2 more sources

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies

open access: yesActa Pharmaceutica Sinica B, 2021
The management of the central nervous system (CNS) disorders is challenging, due to the need of drugs to cross the blood‒brain barrier (BBB) and reach the brain. Among the various strategies that have been studied to circumvent this challenge, the use of
Cláudia Pina Costa   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy